Form 4: Fulgent Genetics CSO Reports Future Stock Disposition for Tax Withholding

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, reported a future disposition of 1,642 common shares at $18.37 each to cover tax obligations related to restricted stock unit vesting.

Summary

• Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, Inc. (FLGT), is the reporting person.
• A disposition of 1,642 shares of common stock is scheduled for July 26, 2025.
• The shares are being disposed of at a price of $18.37 per share.
• The transaction code 'F' indicates shares were withheld to satisfy tax withholding obligations.
• This withholding is related to the vesting of restricted stock units (RSUs) that originated from an Agreement and Plan of Merger dated November 7, 2022.
• Following this transaction, Hanlin Gao will beneficially own 959,639 shares of common stock.
• The original awards were reported on a Form 4 filed on November 9, 2022.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction for tax withholding purposes, which is a standard part of executive compensation and does not indicate positive or negative operational performance.

Future Outlook

A pre-planned future transaction is scheduled for July 26, 2025, involving the withholding of shares to cover tax obligations arising from the vesting of restricted stock units.

Industry Context

This is a company-specific insider transaction related to executive compensation, which is a routine event and does not directly reflect broader industry trends or competitive dynamics.

Related Party Transactions

• This transaction involves an insider (Chief Scientific Officer Hanlin Gao) and is related to the vesting of restricted stock units as part of his compensation package, specifically for tax withholding purposes.

Stakeholder Impact

• Minimal direct impact on shareholders due to the small number of shares involved in a routine tax withholding transaction.
• Primarily impacts the reporting person's beneficial ownership.

Next Steps

• Completion of the disposition of 1,642 common shares on July 26, 2025, to satisfy tax withholding obligations.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned disposition of shares by a Chief Scientific Officer to cover tax obligations related to restricted stock unit vesting. Such transactions are common and do not reflect on the company's operational performance or future prospects, thus warranting no change in investment recommendation based solely on this filing.

Keywords

Fulgent Genetics, FLGT, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, RSU, Hanlin Gao, Chief Scientific Officer